
Li N. Komatsu
Examiner (ID: 2294, Phone: (571)270-3534 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654 |
| Total Applications | 899 |
| Issued Applications | 480 |
| Pending Applications | 135 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10102686
[patent_doc_number] => 09138456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Lipopeptide compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 14/096346
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14150
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/096346 | Lipopeptide compositions and related methods | Dec 3, 2013 | Issued |
Array
(
[id] => 11799574
[patent_doc_number] => 09540363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein'
[patent_app_type] => utility
[patent_app_number] => 14/095313
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11774
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095313
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/095313 | Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein | Dec 2, 2013 | Issued |
Array
(
[id] => 10057335
[patent_doc_number] => 09096679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Peptide compounds and methods of production and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/095826
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 29961
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095826
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/095826 | Peptide compounds and methods of production and use thereof | Dec 2, 2013 | Issued |
Array
(
[id] => 10997414
[patent_doc_number] => 20160194359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/443200
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 83080
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443200
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443200 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | Nov 14, 2013 | Abandoned |
Array
(
[id] => 10114794
[patent_doc_number] => 09149659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Cosmetic composition for increasing hyaluronic acid synthesis in skin and its use for repairing wrinkles'
[patent_app_type] => utility
[patent_app_number] => 14/080171
[patent_app_country] => US
[patent_app_date] => 2013-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3580
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080171
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/080171 | Cosmetic composition for increasing hyaluronic acid synthesis in skin and its use for repairing wrinkles | Nov 13, 2013 | Issued |
Array
(
[id] => 11581793
[patent_doc_number] => 09636413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Conjugates for treating diseases caused by PSMA expressing cells'
[patent_app_type] => utility
[patent_app_number] => 14/443212
[patent_app_country] => US
[patent_app_date] => 2013-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 26070
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443212 | Conjugates for treating diseases caused by PSMA expressing cells | Nov 13, 2013 | Issued |
Array
(
[id] => 11283755
[patent_doc_number] => 09499600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Long-acting single-chain insulin analogues'
[patent_app_type] => utility
[patent_app_number] => 14/440540
[patent_app_country] => US
[patent_app_date] => 2013-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7769
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440540
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440540 | Long-acting single-chain insulin analogues | Nov 4, 2013 | Issued |
Array
(
[id] => 9307093
[patent_doc_number] => 20140045767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Topical Palmitoyl Glutathione Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/061450
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4551
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14061450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/061450 | Topical palmitoyl glutathione formulations | Oct 22, 2013 | Issued |
Array
(
[id] => 9517848
[patent_doc_number] => 20140154340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'METHODS TO TREAT CANCER USING CYCLOSPORINE AND CYCLOSPORINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/057780
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10254
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057780
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057780 | Methods to treat cancer using cyclosporine and cyclosporine derivatives | Oct 17, 2013 | Issued |
Array
(
[id] => 10191864
[patent_doc_number] => 09220758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Calcitonin products and therapies for treating inflammatory or degenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 14/046501
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 7574
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046501
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046501 | Calcitonin products and therapies for treating inflammatory or degenerative diseases | Oct 3, 2013 | Issued |
Array
(
[id] => 10089040
[patent_doc_number] => 09125843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Methods and compositions for improving the appearance of skin'
[patent_app_type] => utility
[patent_app_number] => 14/045075
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10214
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045075 | Methods and compositions for improving the appearance of skin | Oct 2, 2013 | Issued |
Array
(
[id] => 11343500
[patent_doc_number] => 09527895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'CAPCNA peptide therapeutics for cancer'
[patent_app_type] => utility
[patent_app_number] => 14/045223
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13416
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045223
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045223 | CAPCNA peptide therapeutics for cancer | Oct 2, 2013 | Issued |
Array
(
[id] => 9435968
[patent_doc_number] => 20140113875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'NOVEL SELF-ASSEMBLING DRUG AMPHIPHILES AND METHODS FOR SYNTHESIS AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/044329
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 17027
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/044329 | Self-assembling drug amphiphiles and methods for synthesis and use | Oct 1, 2013 | Issued |
Array
(
[id] => 9491631
[patent_doc_number] => 20140142037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'SITE-DIRECTED MONO-SUBSTITUTED PEGYLATED EXENDIN ANALOG AND PREPARATION METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/042544
[patent_app_country] => US
[patent_app_date] => 2013-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4440
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14042544
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/042544 | SITE-DIRECTED MONO-SUBSTITUTED PEGYLATED EXENDIN ANALOG AND PREPARATION METHOD THEREFOR | Sep 29, 2013 | Abandoned |
Array
(
[id] => 9477806
[patent_doc_number] => 20140135269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Peptide And Protein-Based Formula For Improving The Appearance Of Skin'
[patent_app_type] => utility
[patent_app_number] => 14/038047
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2166
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038047 | Peptide And Protein-Based Formula For Improving The Appearance Of Skin | Sep 25, 2013 | Abandoned |
Array
(
[id] => 11449274
[patent_doc_number] => 09572900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate'
[patent_app_type] => utility
[patent_app_number] => 14/429644
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 86
[patent_no_of_words] => 14396
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429644
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429644 | Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate | Sep 16, 2013 | Issued |
Array
(
[id] => 10001471
[patent_doc_number] => 09045550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Peptides and compositions for prevention of cell adhesion and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 14/016480
[patent_app_country] => US
[patent_app_date] => 2013-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7278
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016480
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016480 | Peptides and compositions for prevention of cell adhesion and methods of using same | Sep 2, 2013 | Issued |
Array
(
[id] => 10412667
[patent_doc_number] => 20150297676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/426324
[patent_app_country] => US
[patent_app_date] => 2013-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8304
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426324
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426324 | COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES | Sep 1, 2013 | Abandoned |
Array
(
[id] => 10333225
[patent_doc_number] => 20150218229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Methods and Peptides for Preventing and Treating A BCR-ABL and a C-ABL Associated Disease'
[patent_app_type] => utility
[patent_app_number] => 14/422918
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30757
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422918
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422918 | Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease | Aug 29, 2013 | Issued |
Array
(
[id] => 9463896
[patent_doc_number] => 20140128323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide'
[patent_app_type] => utility
[patent_app_number] => 13/987544
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 6189
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/987544 | Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide | Aug 5, 2013 | Issued |